Ruediger Ridder

4.5k total citations · 1 hit paper
36 papers, 3.4k citations indexed

About

Ruediger Ridder is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Ruediger Ridder has authored 36 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 12 papers in Surgery and 12 papers in Oncology. Recurrent topics in Ruediger Ridder's work include Cervical Cancer and HPV Research (29 papers), Colorectal and Anal Carcinomas (7 papers) and Genital Health and Disease (7 papers). Ruediger Ridder is often cited by papers focused on Cervical Cancer and HPV Research (29 papers), Colorectal and Anal Carcinomas (7 papers) and Genital Health and Disease (7 papers). Ruediger Ridder collaborates with scholars based in Germany, United States and France. Ruediger Ridder's co-authors include Magnus von Knebel Doeberitz, Dietmar Schmidt, Ruediger Klaes, Christine Bergeron, Gisela Dallenbach-Hellweg, Ulrich Petry, W. Rudy, Dimitry Spitkovsky, Marcus J. Trunk and Karin Denton and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Ruediger Ridder

36 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

2001 826 citations Ruediger Klaes, Dimitry Spitkovsky et al. International Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruediger Ridder Germany	26	2.6k	1.4k	870	866	326	36	3.4k
Anco Molijn Netherlands	30	2.6k 1.0×	1.1k 0.8×	522 0.6×	1.1k 1.3×	336 1.0×	57	3.4k
Ruediger Klaes Germany	14	1.5k 0.6×	615 0.5×	567 0.7×	661 0.8×	273 0.8×	24	2.0k
Svetlana Vinokurova Russia	24	1.7k 0.6×	621 0.5×	524 0.6×	792 0.9×	424 1.3×	54	2.2k
B Hagmar Sweden	36	1.9k 0.7×	931 0.7×	825 0.9×	907 1.0×	501 1.5×	115	3.5k
Anna Gillio‐Tos Italy	24	2.1k 0.8×	1.0k 0.8×	578 0.7×	767 0.9×	171 0.5×	51	2.8k
A. Kathrine Lie Norway	24	1.0k 0.4×	673 0.5×	558 0.6×	578 0.7×	394 1.2×	44	2.2k
Miriam Reuschenbach Germany	32	1.1k 0.4×	872 0.6×	860 1.0×	581 0.7×	353 1.1×	77	2.6k
Albertus T. Hesselink Netherlands	33	2.9k 1.1×	1.5k 1.1×	754 0.9×	1.3k 1.5×	498 1.5×	52	3.8k
Jesper Bonde Denmark	30	2.0k 0.8×	699 0.5×	617 0.7×	732 0.8×	110 0.3×	111	2.5k
Linda Ho United Kingdom	25	2.5k 1.0×	1.0k 0.8×	538 0.6×	651 0.8×	147 0.5×	47	2.8k

Countries citing papers authored by Ruediger Ridder

Since Specialization

Citations

This map shows the geographic impact of Ruediger Ridder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Ridder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Ridder more than expected).

Fields of papers citing papers by Ruediger Ridder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruediger Ridder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Ridder. The network helps show where Ruediger Ridder may publish in the future.

Co-authorship network of co-authors of Ruediger Ridder

This figure shows the co-authorship network connecting the top 25 collaborators of Ruediger Ridder. A scholar is included among the top collaborators of Ruediger Ridder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruediger Ridder. Ruediger Ridder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Safaeian, Mahboobeh, Thomas C. Wright, Mark H. Stoler, et al.. (2021). The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase. American Journal of Obstetrics and Gynecology. 225(3). 278.e1–278.e16. 16 indexed citations

Preti, Mario, John Charles Rotondo, Dana Holzinger, et al.. (2020). Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infectious Agents and Cancer. 15(1). 20–20. 58 indexed citations

Ursu, Ramona Gabriela, Mihai Danciu, Irene Alexandra Spiridon, et al.. (2018). Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania. PLoS ONE. 13(6). e0199663–e0199663. 20 indexed citations

Wright, Thomas C., Catherine Behrens, James Ranger‐Moore, et al.. (2016). Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Gynecologic Oncology. 144(1). 51–56. 107 indexed citations

Ikenberg, Hans, Christine Bergeron, Dietmar Schmidt, et al.. (2013). Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study. JNCI Journal of the National Cancer Institute. 105(20). 1550–1557. 168 indexed citations

Schmidt, Dietmar, Alexander Luyten, Axel Reinecke‐Lüthge, et al.. (2011). Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecologic Oncology. 121(3). 505–509. 167 indexed citations

Schmidt, Dietmar, et al.. (2011). p16/ki‐67 dual‐stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology. Cancer Cytopathology. 119(3). 158–166. 174 indexed citations

Reuschenbach, Miriam, C. von Knebel Doeberitz, Svetlana Vinokurova, et al.. (2011). Evaluation of cervical cone biopsies for coexpression of p16^INK4a and Ki‐67 in epithelial cells. International Journal of Cancer. 130(2). 388–394. 57 indexed citations

Horn, Lars‐Christian, Anja Reichert, Marcus J. Trunk, et al.. (2008). Immunostaining for p16INK4a Used as a Conjunctive Tool Improves Interobserver Agreement of the Histologic Diagnosis of Cervical Intraepithelial Neoplasia. The American Journal of Surgical Pathology. 32(4). 502–512. 75 indexed citations

10.

Mao, Constance, Mujun Yu, Nancy B. Kiviat, et al.. (2007). Evaluation of a new p16^INK4A ELISA test and a high‐risk HPV DNA test for cervical cancer screening: Results from proof‐of‐concept study. International Journal of Cancer. 120(11). 2435–2438. 31 indexed citations

11.

Wentzensen, Nicolas, Monika Hampl, Matthias Herkert, et al.. (2006). Identification of high‐grade cervical dysplasia by the detection of p16^INK4a in cell lysates obtained from cervical samples. Cancer. 107(9). 2307–2313. 34 indexed citations

12.

Trunk, Marcus J., Gisela Dallenbach-Hellweg, Ruediger Ridder, et al.. (2004). Morphologic Characteristics of p16<sup>INK4a</sup>-Positive Cells in Cervical Cytology Samples. Acta Cytologica. 48(6). 771–782. 64 indexed citations

13.

Schwarzbach, Matthias, Robert Koesters, Anja Germann, et al.. (2004). Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas. Oncogene. 23(40). 6798–6805. 22 indexed citations

14.

Ishikawa, Mitsuya, Takuma Fujii, Miyuki Saito, et al.. (2003). Correlation of p16INK4A Overexpression with Human Papillomavirus Infection in Cervical Adenocarcinomas. International Journal of Gynecological Pathology. 22(4). 378–385. 43 indexed citations

15.

Schwarzbach, Matthias, Sven Eisold, Frank Willeke, et al.. (2002). Sensitization of sarcoma cells to doxorubicin treatment by concomitant wild-type adeno-associated virus type 2 (AAV-2) infection. International Journal of Oncology. 20(6). 1211–8. 12 indexed citations

16.

Kloor, Matthias, et al.. (2002). Identification and characterization of UEV3, a human cDNA with similarities to inactive E2 ubiquitin-conjugating enzymes. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1579(2-3). 219–224. 9 indexed citations

17.

Eisold, Sven, Susanne Dihlmann, Michael Linnebacher, et al.. (2002). Prevention of chemotherapy‐related toxic side effects by infection with adeno‐associated virus type 2. International Journal of Cancer. 100(5). 606–614. 3 indexed citations

18.

Woerner, Stefan M., Johannes Gebert, Yan P. Yuan, et al.. (2001). Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair-deficient cancer cells. International Journal of Cancer. 93(1). 12–19. 79 indexed citations

19.

Klaes, Ruediger, Dimitry Spitkovsky, Ruediger Ridder, et al.. (2001). Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. International Journal of Cancer. 92(2). 276–284. 826 indexed citations breakdown →

20.

Klaes, Ruediger, et al.. (1999). No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer. Journal of Molecular Medicine. 77(2). 299–302. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact